Flow Traders U.S.’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
DGM
Flow Traders U.S.'s GMAB Position: Q3 2026 in Review
Flow Traders U.S. opened a new position in Genmab (GMAB) in Q3 2026: 17,773 shares worth $634K. The stake represents 0.02% of the portfolio and ranks #559 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in GMAB as recently as Q3 2025.
Flow Traders U.S. first reported a position in GMAB in Q3 2025 and has held it in 2 quarters since. 329 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Flow Traders U.S. held 17,773 shares of Genmab worth $634K as of Q3 2026.
- Genmab was a new Flow Traders U.S. position in Q3 2026.
- Genmab made up 0.02% of Flow Traders U.S.'s portfolio in Q3 2026, its #559 holding.
- Flow Traders U.S. first reported a position in Genmab in Q3 2025 and has held it in 2 quarters since.
- 329 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Flow Traders U.S.'s 13F filing for Q3 2026, filed 13 Nov 2026.